These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25951351)

  • 1. Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer.
    Jacobs J; Zwaenepoel K; Rolfo C; Van den Bossche J; Deben C; Silence K; Hermans C; Smits E; Van Schil P; Lardon F; Deschoolmeester V; Pauwels P
    Oncotarget; 2015 May; 6(15):13462-75. PubMed ID: 25951351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pVHL/HIF-regulated CD70 expression is associated with infiltration of CD27+ lymphocytes and increased serum levels of soluble CD27 in clear cell renal cell carcinoma.
    Ruf M; Mittmann C; Nowicka AM; Hartmann A; Hermanns T; Poyet C; van den Broek M; Sulser T; Moch H; Schraml P
    Clin Cancer Res; 2015 Feb; 21(4):889-98. PubMed ID: 25691774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies.
    Al Sayed MF; Ruckstuhl CA; Hilmenyuk T; Claus C; Bourquin JP; Bornhauser BC; Radpour R; Riether C; Ochsenbein AF
    Blood; 2017 Jul; 130(3):297-309. PubMed ID: 28495792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARGX-110, a highly potent antibody targeting CD70, eliminates tumors via both enhanced ADCC and immune checkpoint blockade.
    Silence K; Dreier T; Moshir M; Ulrichts P; Gabriels SM; Saunders M; Wajant H; Brouckaert P; Huyghe L; Van Hauwermeiren T; Thibault A; De Haard HJ
    MAbs; 2014; 6(2):523-32. PubMed ID: 24492296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic targeting of CD70 and CD27.
    Wajant H
    Expert Opin Ther Targets; 2016 Aug; 20(8):959-73. PubMed ID: 26914723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of CD70-CD27 interaction inhibits induction of allergic lung inflammation in mice.
    Makino F; Ito J; Abe Y; Harada N; Kamachi F; Yagita H; Takahashi K; Okumura K; Akiba H
    Am J Respir Cell Mol Biol; 2012 Sep; 47(3):298-305. PubMed ID: 22499851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation.
    Hintzen RQ; Lens SM; Lammers K; Kuiper H; Beckmann MP; van Lier RA
    J Immunol; 1995 Mar; 154(6):2612-23. PubMed ID: 7876536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD70-CD27 interactions provide survival and proliferative signals that regulate T cell receptor-driven activation of human γδ peripheral blood lymphocytes.
    DeBarros A; Chaves-Ferreira M; d'Orey F; Ribot JC; Silva-Santos B
    Eur J Immunol; 2011 Jan; 41(1):195-201. PubMed ID: 21182090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology.
    Nolte MA; van Olffen RW; van Gisbergen KP; van Lier RA
    Immunol Rev; 2009 May; 229(1):216-31. PubMed ID: 19426224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
    Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC
    Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous CD27 triggering in vivo strongly reduces NK cell numbers.
    De Colvenaer V; Taveirne S; Hamann J; de Bruin AM; De Smedt M; Taghon T; Vandekerckhove B; Plum J; van Lier R; Leclercq G
    Eur J Immunol; 2010 Apr; 40(4):1107-17. PubMed ID: 20140903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD27 signaling increases the frequency of regulatory T cells and promotes tumor growth.
    Claus C; Riether C; Schürch C; Matter MS; Hilmenyuk T; Ochsenbein AF
    Cancer Res; 2012 Jul; 72(14):3664-76. PubMed ID: 22628427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer.
    Jin Y; Zhang P; Li J; Zhao J; Liu C; Yang F; Yang D; Gao A; Lin W; Ma X; Sun Y
    Int J Clin Exp Pathol; 2015; 8(11):13987-95. PubMed ID: 26823710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression.
    Kataki A; Scheid P; Piet M; Marie B; Martinet N; Martinet Y; Vignaud JM
    J Lab Clin Med; 2002 Nov; 140(5):320-8. PubMed ID: 12434133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD70: An emerging target in cancer immunotherapy.
    Jacobs J; Deschoolmeester V; Zwaenepoel K; Rolfo C; Silence K; Rottey S; Lardon F; Smits E; Pauwels P
    Pharmacol Ther; 2015 Nov; 155():1-10. PubMed ID: 26213107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD70 in nasal natural killer/T cell lymphoma cell lines and patients; its role for cell proliferation through binding to soluble CD27.
    Yoshino K; Kishibe K; Nagato T; Ueda S; Komabayashi Y; Takahara M; Harabuchi Y
    Br J Haematol; 2013 Feb; 160(3):331-42. PubMed ID: 23206232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical characterization of SGN-70, a humanized antibody directed against CD70.
    McEarchern JA; Smith LM; McDonagh CF; Klussman K; Gordon KA; Morris-Tilden CA; Duniho S; Ryan M; Boursalian TE; Carter PJ; Grewal IS; Law CL
    Clin Cancer Res; 2008 Dec; 14(23):7763-72. PubMed ID: 19047103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cells compete by cleaving cell surface CD27 and blocking access to CD70-bearing APCs.
    Burchill MA; Tamburini BA; Kedl RM
    Eur J Immunol; 2015 Nov; 45(11):3140-9. PubMed ID: 26179759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune escape for renal cell carcinoma: CD70 mediates apoptosis in lymphocytes.
    Diegmann J; Junker K; Loncarevic IF; Michel S; Schimmel B; von Eggeling F
    Neoplasia; 2006 Nov; 8(11):933-8. PubMed ID: 17132225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting CD70 for human therapeutic use.
    Boursalian TE; McEarchern JA; Law CL; Grewal IS
    Adv Exp Med Biol; 2009; 647():108-19. PubMed ID: 19760069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.